Valion Bio, Inc. (VBIO)
1.17
-0.06
(-4.88%)
USD |
NASDAQ |
Oct 16, 16:00
1.14
-0.03
(-2.56%)
After-Hours: 20:00
Valion Bio Market Cap : 0.1943M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 0.1943M |
| October 15, 2026 | 0.2043M |
| October 14, 2026 | 0.2408M |
| October 13, 2026 | 0.2575M |
| October 12, 2026 | 0.279M |
| October 09, 2026 | 0.3555M |
| October 08, 2026 | 0.3671M |
| October 07, 2026 | 0.3638M |
| October 06, 2026 | 0.3953M |
| October 05, 2026 | 0.4119M |
| October 02, 2026 | 0.4302M |
| October 01, 2026 | 0.4169M |
| September 30, 2026 | 0.4651M |
| September 29, 2026 | 0.4701M |
| September 28, 2026 | 0.4485M |
| September 25, 2026 | 0.5033M |
| September 24, 2026 | 0.578M |
| September 23, 2026 | 0.4535M |
| September 22, 2026 | 0.4136M |
| September 21, 2026 | 0.3953M |
| September 18, 2026 | 0.3521M |
| September 17, 2026 | 0.3704M |
| September 16, 2026 | 0.3455M |
| September 15, 2026 | 0.3505M |
| September 14, 2026 | 0.3488M |
| Date | Value |
|---|---|
| September 11, 2026 | 0.3754M |
| September 10, 2026 | 0.3654M |
| September 09, 2026 | 0.3986M |
| September 08, 2026 | 0.4152M |
| September 04, 2026 | 0.4601M |
| September 03, 2026 | 0.4651M |
| September 02, 2026 | 0.5182M |
| September 01, 2026 | 0.5099M |
| August 31, 2026 | 0.593M |
| August 28, 2026 | 0.502M |
| August 27, 2026 | 0.5091M |
| August 26, 2026 | 0.6478M |
| August 25, 2026 | 16.50M |
| August 24, 2026 | 17.23M |
| August 21, 2026 | 12.73M |
| August 20, 2026 | 12.67M |
| August 19, 2026 | 13.95M |
| August 18, 2026 | 16.67M |
| August 17, 2026 | 18.94M |
| August 14, 2026 | 19.78M |
| August 13, 2026 | 17.73M |
| August 12, 2026 | 23.46M |
| August 11, 2026 | 32.18M |
| August 10, 2026 | 29.89M |
| August 07, 2026 | 29.62M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Outlook Therapeutics, Inc. | 91.34M |
| Agenus, Inc. | 257.40M |
| Amgen, Inc. | 233.80B |
| Anika Therapeutics, Inc. | 267.39M |
| BioCryst Pharmaceuticals, Inc. | 1.989B |
Market Cap Related Metrics
| PS Ratio | 0.6784 |
| Price to Book Value | 0.0458 |
| Price | 1.17 |
| Earnings Yield | -17.97K% |